BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced that the U.S. Food and Drug Administration has approved an expanded indication for BYETTAA injection.

[Daniel Haszard]

Daniel Haszard wrote:

Eli Lilly sells a drug {ZYPREXA} that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!
Eli Lilly has made $38 billion on Zyprexa and it was way oversold and caused diabetes and in some cases sudden death.
Eli Lilly has received a huge criminal fine over their Zyprexa cash cow,add it all up comes to $4.6 billion, in Zyprexa settlements,fines,litigation.
Addictive Zyprexa was pushed by Lilly Drug Reps.
They called it the "Five at Five" (5 mg at 5 pm to keep nursing home patients subdued and sleepy) and "VIVA ZYPREXA" (Zyprexa for everybody) campaigns to off label market Eli Lilly Zyprexa as a fix for unapproved usage.

Eli Lilly is 'reaping the whirlwind' for aggressive marketing of Zyprexa that has caused suffering and deaths.
There must be millions out there harmed by this drug.
Did you know that Lilly made $ billions last year on diabetic meds, Actos,Humulin and Byetta?
Yes! They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!
----
Daniel Haszard http://1url.com/0vi

http://1url.com/0vi